This is a preprint of an article accepted for publication in Luminescence:
Photodynamic therapy (PDT) is based on photodynamic effect, which involves the combination of light, an organic dye -photosensitizer and molecular oxygen. Upon irradiation by laser, the photosensitizer is excited to the first excited singlet state, which can react in two ways. A Type I mechanism involves hydrogen-atom abstraction or electron-transfer reactions to yield free radicals and radicals ions. A Type II results from an energy transfer and generates singlet oxygen. Various chemiluminescent compounds (e.g. luminol and its derivatives) have been studied in order to find suitable and specific probes for detection of particular reactive oxygen species (ROS). Recently Cypridina luciferin analogues (CLA and MCLA) are thought to emit light only when reacting with superoxide anion and singlet oxygen. Luminol, CLA and MCLA CL were studied in three ROS generating chemical systems in vitro (HRP -H 2 O 2 , CuSO 4 -H 2 O 2 and NaClO -H 2 O 2 system). Measurements were carried out in phosphate buffer (pH 7.4) at 25°C and 37°C using luminometer Fluoroskan Ascent FL. Superoxide dismutase and sodium azide were used as specific scavenger of superoxide anion radical and quencher of singlet oxygen, respectively. Their effect was compared with that of Trolox (water soluble analogue of vitamin E), which should scavenge all reactive species present in the reaction mixture, and tryptophan. As the photodynamic systems we used e.g. phthalocyanines and chlorophyll a. The declared specifity of Cypridina luciferin analogues chemiluminescence based on superoxide and singlet oxygen and the suitability of this prove is discussed.
